» Articles » PMID: 29020224

Approach to the Investigation and Management of Patients With Candida Auris, an Emerging Multidrug-Resistant Yeast

Overview
Journal Clin Infect Dis
Date 2017 Oct 12
PMID 29020224
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Candida auris is an emerging, multidrug-resistant yeast that can spread in healthcare settings. It can cause invasive infections with high mortality and is difficult to identify using traditional yeast identification methods. Candida auris has been reported in more than a dozen countries, and as of August 2017, 112 clinical cases have been reported in the United States. Candida auris can colonize skin and persist in the healthcare environment, allowing for transmission between patients. Prompt investigation and aggressive interventions, including notification to public health agencies, implementation of contact precautions, thorough environmental cleaning and disinfection, infection control assessments, contact tracing and screening of contacts to assess for colonization, and retrospective review of microbiology records and prospective surveillance for cases at laboratories are all needed to limit the spread of C. auris. This review summarizes the current recommended approach to manage cases and control transmission of C. auris in healthcare facilities.

Citing Articles

: Epidemiology and Antifungal Strategy.

Eix E, Nett J Annu Rev Med. 2024; 76(1):57-67.

PMID: 39656947 PMC: 11808652. DOI: 10.1146/annurev-med-061523-021233.


What makes pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs.

Rhodes J, Jacobs J, Dennis E, Manjari S, Banavali N, Marlow R Antimicrob Agents Chemother. 2024; 68(10):e0091124.

PMID: 39297640 PMC: 11459930. DOI: 10.1128/aac.00911-24.


Synergistic Effect of Essential Oils and Antifungal Agents in Fighting Resistant Clinical Isolates of .

Cavallo L, Menotti F, Roana J, Costa C, Longo F, Pagano C Pharmaceutics. 2024; 16(7).

PMID: 39065654 PMC: 11279409. DOI: 10.3390/pharmaceutics16070957.


Skin and hard surface disinfection against - What we know today.

Omardien S, Teska P Front Med (Lausanne). 2024; 11:1312929.

PMID: 38384416 PMC: 10879571. DOI: 10.3389/fmed.2024.1312929.


The Gordian Knot of : If You Cannot Cut It, Prevent It.

Rapti V, Iliopoulou K, Poulakou G Pathogens. 2023; 12(12).

PMID: 38133327 PMC: 10747958. DOI: 10.3390/pathogens12121444.


References
1.
Lautenbach E, Nachamkin I, Hu B, Fishman N, Tolomeo P, Prasad P . Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples. Infect Control Hosp Epidemiol. 2009; 30(4):380-2. PMC: 2665909. DOI: 10.1086/596045. View

2.
Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H . Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol. 2009; 53(1):41-4. DOI: 10.1111/j.1348-0421.2008.00083.x. View

3.
Prakash A, Sharma C, Singh A, Kumar Singh P, Kumar A, Hagen F . Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. Clin Microbiol Infect. 2015; 22(3):277.e1-9. DOI: 10.1016/j.cmi.2015.10.022. View

4.
Schelenz S, Hagen F, Rhodes J, Abdolrasouli A, Chowdhary A, Hall A . First hospital outbreak of the globally emerging in a European hospital. Antimicrob Resist Infect Control. 2016; 5:35. PMC: 5069812. DOI: 10.1186/s13756-016-0132-5. View

5.
Piedrahita C, Cadnum J, Jencson A, Shaikh A, Ghannoum M, Donskey C . Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris and Other Candida Species. Infect Control Hosp Epidemiol. 2017; 38(9):1107-1109. DOI: 10.1017/ice.2017.127. View